Cargando…

A case of adrenocortical carcinoma accompanying secondary acute adrenal hypofunction postoperation

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare, heterogeneous malignancy with a poor prognosis. ACCs are classified as functioning and non-functioning. The pathogenesis of ACC remains elusive, and diagnosis of ACC is currently based on pathology. In the absence of other effective approaches, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kou, Kai, Zhang, Haiwen, Zhang, Conggui, Xie, Enbo, Chen, Yuguo, Wang, Guangyi, Lv, Guoyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836435/
https://www.ncbi.nlm.nih.gov/pubmed/29506536
http://dx.doi.org/10.1186/s12957-018-1326-5
Descripción
Sumario:BACKGROUND: Adrenocortical carcinoma (ACC) is a rare, heterogeneous malignancy with a poor prognosis. ACCs are classified as functioning and non-functioning. The pathogenesis of ACC remains elusive, and diagnosis of ACC is currently based on pathology. In the absence of other effective approaches, surgical resection is the preferred treatment option. CASE PRESENTATION: Here, we report a case of ACC in the retroperitoneum. The patient underwent radical adrenalectomy and remained disease-free throughout a 6-month follow-up. CONCLUSIONS: Radical surgical resection is an efficient therapy for ACC, and hydrocortisone can be used to alleviate symptoms of secondary acute adrenal hypofunction.